GENEVA, Oct. 18 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (No.7 Kunlunshan Road, Economic And Technological Development ZoneLianyungang, Jiangsu 222047), 江苏恒瑞医药股份有限公司 (中国江苏省连云港市经济技术开发区昆仑山路7号) filed a patent application (PCT/CN2025/087704) for "METHOD FOR TREATING TSLP-ASSOCIATED INFLAMMATORY DISEASE USING ANTI-TSLP ANTIBODY" on Apr 08, 2025. With publication no. WO/2025/214333, the details related to the patent application was published on Oct 16, 2025.
Notably, the patent application was submitted under the I...